Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 58

1.

Vaccines in the Treatment of Substance Abuse.

Shorter D, Kosten TR.

Focus (Am Psychiatr Publ). 2011 Dec 1;2011(9):25-30.

2.

Pharmacotherapy of dual substance abuse and dependence.

Kenna GA, Nielsen DM, Mello P, Schiesl A, Swift RM.

CNS Drugs. 2007;21(3):213-37. Review.

PMID:
17338593
3.

A qualitative review of issues arising in the use of psycho-stimulant medications in patients with ADHD and co-morbid substance use disorders.

Kollins SH.

Curr Med Res Opin. 2008 May;24(5):1345-57. doi: 10.1185/030079908X280707 . Epub 2008 Apr 1. Review.

PMID:
18384709
4.

Understanding the neurobiology, assessment, and treatment of substances of abuse and dependence: a guide for the critical care nurse.

Genung V.

Crit Care Nurs Clin North Am. 2012 Mar;24(1):117-30. doi: 10.1016/j.ccell.2012.01.007. Review.

PMID:
22405717
5.

A naturalistic study of the effects of pharmacotherapy on substance use disorders among ADHD adults.

Faraone SV, Biederman J, Wilens TE, Adamson J.

Psychol Med. 2007 Dec;37(12):1743-52. Epub 2007 Mar 12.

PMID:
17349106
6.

New medication strategies for comorbid substance use and bipolar affective disorders.

Kosten TR, Kosten TA.

Biol Psychiatry. 2004 Nov 15;56(10):771-7.

PMID:
15556122
7.

New anticonvulsants: a review of applications for the management of substance abuse disorders.

Gentry JR, Hill C, Malcolm R.

Ann Clin Psychiatry. 2002 Dec;14(4):233-45. Review.

PMID:
12630659
8.
9.

Agonist-like, replacement pharmacotherapy for stimulant abuse and dependence.

Grabowski J, Shearer J, Merrill J, Negus SS.

Addict Behav. 2004 Sep;29(7):1439-64. Review.

PMID:
15345275
10.

The management of treatment resistance in depressed patients with substance use disorders.

Nunes EV, Deliyannides D, Donovan S, McGrath PJ.

Psychiatr Clin North Am. 1996 Jun;19(2):311-27. Review.

PMID:
8827192
11.

Long-term adjunctive quetiapine may reduce substance use--a preliminary retrospective study.

Sattar SP, Schultz SK, Arndt S, Soundy T, Petty F.

S D Med. 2007 Nov;60(11):437, 439-41, 443 passim.

PMID:
18196687
12.

The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid substance use disorders.

Beaulieu S, Saury S, Sareen J, Tremblay J, Schütz CG, McIntyre RS, Schaffer A; Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force.

Ann Clin Psychiatry. 2012 Feb;24(1):38-55. Review.

PMID:
22303521
13.

The use of medication for relapse prevention in substance dependence disorders.

Welsh CJ, Liberto J.

J Psychiatr Pract. 2001 Jan;7(1):15-31.

PMID:
15990498
14.

Pharmacotherapy for substance abuse disorders in adolescence.

Kaplan G, Ivanov I.

Pediatr Clin North Am. 2011 Feb;58(1):243-58, xiii. doi: 10.1016/j.pcl.2010.10.010. Review.

PMID:
21281859
15.

Substance abuse in patients with attention-deficit/hyperactivity disorder.

Bukstein O.

Medscape J Med. 2008 Jan 31;10(1):24. Review.

16.

Effectiveness of short-term olanzapine in patients with bipolar I disorder, with or without comorbidity with substance use disorder.

Sani G, Kotzalidis GD, Vöhringer P, Pucci D, Simonetti A, Manfredi G, Savoja V, Tamorri SM, Mazzarini L, Pacchiarotti I, Telesforo CL, Ferracuti S, Brugnoli R, Ambrosi E, Caloro M, Del Casale A, Koukopoulos AE, Vergne DE, Girardi P, Ghaemi SN.

J Clin Psychopharmacol. 2013 Apr;33(2):231-5. doi: 10.1097/JCP.0b013e318287019c.

PMID:
23422396
17.

Prevalence and correlates of alcohol and other substance use disorders in young adulthood: A population-based study.

Latvala A, Tuulio-Henriksson A, Perälä J, Saarni SI, Aalto-Setälä T, Aro H, Korhonen T, Koskinen S, Lönnqvist J, Kaprio J, Suvisaari J.

BMC Psychiatry. 2009 Nov 19;9:73. doi: 10.1186/1471-244X-9-73.

18.

Vaccines against drugs of abuse: a viable treatment option?

Kantak KM.

Drugs. 2003;63(4):341-52. Review.

PMID:
12558457
19.

Substance use problems and associated psychiatric symptoms among adolescents in primary care.

Shrier LA, Harris SK, Kurland M, Knight JR.

Pediatrics. 2003 Jun;111(6 Pt 1):e699-705.

PMID:
12777588
20.

The prevalence and significance of substance use disorders in bipolar type I and II disorder.

Cerullo MA, Strakowski SM.

Subst Abuse Treat Prev Policy. 2007 Oct 1;2:29.

Items per page

Supplemental Content

Write to the Help Desk